Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07ECH
|
|||
| Former ID |
DNC001493
|
|||
| Drug Name |
V-165
|
|||
| Synonyms |
V-165; 223393-69-9; 5-(4-nitrophenyl)-2,8-dithioxo-5,7,8,9-tetrahydro-2H-pyrano[2,3-d:6,5-d']dipyrimidine-4,6(1H,3H)-dione; NSC705851; AC1MFLNX; V 165; CHEMBL178865; SCHEMBL13788910; MolPort-000-782-351; MolPort-000-751-505; ZINC13799665; STL349538; STL150551; AKOS005750605; AKOS022142146; NSC-705851; MCULE-8450455381; NCI60_037697; ST51021506; 4-(4-nitrophenyl)-2,2-bis(sulfanyl)[ ]-4,4-diol; 2,8-Dimercapto-5-(4-nitro-phenyl)-5H-pyrano[2,3-d; 2,8-dimercapto-5-(4-nitrophenyl)-5h-pyrano[2,3-d:6,5-d']dipyrimidine-4,6-diol
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H9N5O5S2
|
|||
| Canonical SMILES |
C1=CC(=CC=C1C2C3=C(NC(=S)NC3=O)OC4=C2C(=O)NC(=S)N4)[N+](=O)[O-]
|
|||
| InChI |
1S/C15H9N5O5S2/c21-10-8-7(5-1-3-6(4-2-5)20(23)24)9-11(22)17-15(27)19-13(9)25-12(8)18-14(26)16-10/h1-4,7H,(H2,16,18,21,26)(H2,17,19,22,27)
|
|||
| InChIKey |
UYLYXNZSRMQYRO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 223393-69-9
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
528872, 3531221, 4802735, 5878923, 7180930, 8922795, 11442049, 15223777, 22425750, 25728156, 28439102, 34489381, 49910316, 53193857, 88246904, 88277750, 103442016, 103855738, 111527900, 125279622, 132033232, 134340667, 137670106, 139553811, 143820513, 164102427, 169476494, 179393403, 215741549, 238779432, 246900327
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Integrase (HIV IN) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | New class of HIV integrase inhibitors that block viral replication in cell culture. Curr Biol. 2002 Jul 23;12(14):1169-77. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.